Screening for sexually and blood-borne infections in Ukrainian war refugees in Slovakia

Abstract Background: Sexually transmitted and blood-borne infections (STBBIs) remain a major public health challenge in Europe, with migrant populations facing increased vulnerability due to disrupted healthcare access, social instability, and barriers to early diagnosis. Following the large-scale displacement of Ukrainian war refugees after 2022, targeted surveillance strategies are needed to ensure timely detection and linkage to care. Methods: A cross-sectional observational study implementing active case finding for HIV, syphilis, hepatitis B (HBV), and hepatitis C (HCV) was conducted between September and December 2023 among adult Ukrainian war refugees residing in the Bratislava region, Slovakia. Screening was performed using rapid diagnostic tests in a general practitioner’s office and an outpatient gynecology clinic. Testing was voluntary, conducted by trained healthcare personnel, and supported by a psychologist and mediator to facilitate communication, follow-up, and linkage to specialist care. All reactive results were confirmed by standard laboratory diagnostics. Results: Of 776 individuals approached, 505 (65.1%) consented to testing; 77.4% were women, and the largest age group was 40–49 years. Overall reactivity rates were 1.8% for HCV, 1.0% for HBV, 0.8% for syphilis, and 0.6% for HIV. HIV reactivity among men reached 1.8%. All reactive rapid test results were laboratory-confirmed, and all affected individuals were successfully referred for specialist care and treatment planning. Conclusions: This pilot project demonstrated the feasibility and acceptability of active STBBIs screening integrated into routine outpatient care for Ukrainian war refugees. The observed reactivity rates, particularly for viral hepatitis, reflect the epidemiological situation in Ukraine and highlight the risk of underdiagnosis in displaced populations. Systematic, targeted screening strategies that address linguistic, cultural, and organizational barriers and ensure timely linkage to care are essential to improve migrant health outcomes and to reduce the risk of infectious disease transmission in host countries. Teaser Key Message Pilot screening for HIV, syphilis, HBV, and HCV among Ukrainian war refugees in Slovakia showed reactivity rates of 0.6–1.8%, with 100% linkage to confirmatory diagnostics and care. This demonstrates feasibility of integrated rapid testing in routine outpatient settings. Key Messages Epidemiological Burden: Reactivity rates—HCV 1.8% (9/505), HBV 1.0% (5/505), syphilis 0.8% (4/505), HIV 0.6% overall (1.8% in males)—mirror Ukraine's high endemicity, underscoring underdiagnosis risks in displaced populations post-2022 invasion. Screening Feasibility: Cross-sectional study using high-sensitivity (>99%) rapid tests in GP and gynecology clinics achieved 65.1% uptake (505/776 approached). Psychologist and mediator support ensured voluntary consent and 100% referral to lab confirmation and treatment. Public Health Impact: Culturally adapted, integrated screening overcomes linguistic/cultural barriers, enhances migrant health outcomes, and curbs transmission risks in host countries like Slovakia. Scalable for EU/EEA routine surveillance.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11567692/v1
Primary Topic
HIV, TB, and STIs Epidemiology
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Screening for sexually and blood-borne infections in Ukrainian war refugees in Slovakia

Alexandra Bražinová, Peter Gába, Stepan Reshetár, Terézia Mračková
Research Square
HIV, TB, and STIs Epidemiology
preprint

Screening for sexually and blood-borne infections in Ukrainian war refugees in Slovakia

Alexandra Bražinová, Peter Gába, Stepan Reshetár, Terézia Mračková
preprint en

Abstract

Abstract Background: Sexually transmitted and blood-borne infections (STBBIs) remain a major public health challenge in Europe, with migrant populations facing increased vulnerability due to disrupted healthcare access, social instability, and barriers to early diagnosis. Following the large-scale displacement of Ukrainian war refugees after 2022, targeted surveillance strategies are needed to ensure timely detection and linkage to care. Methods: A cross-sectional observational study implementing active case finding for HIV, syphilis, hepatitis B (HBV), and hepatitis C (HCV) was conducted between September and December 2023 among adult Ukrainian war refugees residing in the Bratislava region, Slovakia. Screening was performed using rapid diagnostic tests in a general practitioner’s office and an outpatient gynecology clinic. Testing was voluntary, conducted by trained healthcare personnel, and supported by a psychologist and mediator to facilitate communication, follow-up, and linkage to specialist care. All reactive results were confirmed by standard laboratory diagnostics. Results: Of 776 individuals approached, 505 (65.1%) consented to testing; 77.4% were women, and the largest age group was 40–49 years. Overall reactivity rates were 1.8% for HCV, 1.0% for HBV, 0.8% for syphilis, and 0.6% for HIV. HIV reactivity among men reached 1.8%. All reactive rapid test results were laboratory-confirmed, and all affected individuals were successfully referred for specialist care and treatment planning. Conclusions: This pilot project demonstrated the feasibility and acceptability of active STBBIs screening integrated into routine outpatient care for Ukrainian war refugees. The observed reactivity rates, particularly for viral hepatitis, reflect the epidemiological situation in Ukraine and highlight the risk of underdiagnosis in displaced populations. Systematic, targeted screening strategies that address linguistic, cultural, and organizational barriers and ensure timely linkage to care are essential to improve migrant health outcomes and to reduce the risk of infectious disease transmission in host countries. Teaser Key Message Pilot screening for HIV, syphilis, HBV, and HCV among Ukrainian war refugees in Slovakia showed reactivity rates of 0.6–1.8%, with 100% linkage to confirmatory diagnostics and care. This demonstrates feasibility of integrated rapid testing in routine outpatient settings. Key Messages Epidemiological Burden: Reactivity rates—HCV 1.8% (9/505), HBV 1.0% (5/505), syphilis 0.8% (4/505), HIV 0.6% overall (1.8% in males)—mirror Ukraine's high endemicity, underscoring underdiagnosis risks in displaced populations post-2022 invasion. Screening Feasibility: Cross-sectional study using high-sensitivity (>99%) rapid tests in GP and gynecology clinics achieved 65.1% uptake (505/776 approached). Psychologist and mediator support ensured voluntary consent and 100% referral to lab confirmation and treatment. Public Health Impact: Culturally adapted, integrated screening overcomes linguistic/cultural barriers, enhances migrant health outcomes, and curbs transmission risks in host countries like Slovakia. Scalable for EU/EEA routine surveillance.

Research Square
Nova Medical (United States) (US), Comenius University Bratislava (SK)
World Health Organization
Good health and well-being, Reduced inequalities
HIV, TB, and STIs Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon